Apogee Therapeutics share price logo

Apogee Therapeutics

NASDAQ: APGE

Large Cap

$135.07

-0.01

(-0.01%)

Live

as on

Apogee Therapeutics Stock Performance

as on September 3, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $135.06
    $135.09
    downward going graph

    0.01%

    Downside

    0.01%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $35.39
    $135.09
    downward going graph

    73.80%

    Downside

    0.01%

    Upside

    downward going graph

Apogee Therapeutics share price movements today

Previous Close
$135.08
Open
$135.07
Volume
1.8M
Market Cap
$10.2B
Day's Low - High
$135.06 - $135.09
52 Week Low - High
$35.39 - $135.09

Apogee Therapeutics Historical Returns

1 Month Return
+ 0.66 %
3 Month Return
+ 48.59 %
1 Year Return
+ 263.78 %
3 Year Return
+ 446.62 %
5 Year Return
0 %

Apogee Therapeutics Stock Fundamentals & Key Indicators

Check Apogee Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$10.2B

EPS (TTM)

-4.34

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-31.12

Industry PE ratio

9.70

PEG Ratio

6.571112747786168

EBITDA

-291.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-29.88%

Apogee Therapeutics Stock Valuation

Track how Apogee Therapeutics P/E has moved over time to understand its valuation trends.

Apogee Therapeutics in the last 4 years

  • Overview

  • Trends

Lowest (-27.04x)

December 31, 2022

Today (-17.89x)

December 31, 2025

Industry (9.70x)

December 31, 2025

Highest (-13.73x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -17.89x

Apogee Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Apogee Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Neutral$10.2BNA-31.120.00%0.00%
StrongBuy$43.9B615.18%-23.130.00%0.00%
StrongBuy$133.4B189.75%30.3886.04%0.00%
Neutral$79.4B-48.24%-24.92-12.57%0.00%
Buy$81.1B30.25%18.8284.86%0.47%

Stock Returns calculator for Apogee Therapeutics Stock including INR - Dollar returns

The Apogee Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Apogee Therapeutics investment value today

Current value as on today

₹3,93,615

Returns

₹2,93,615

(+293.61%)

Returns from Apogee Therapeutics Stock

₹2,63,776 (+263.78%)

Dollar Impact

₹29,839 (+29.84%)

Analyst Recommendation on Apogee Therapeutics Stock

Based on 15 analysts

HOLD

20.00%

Buy

80.00%

Hold

0.00%

Sell

Based on 15 analysts, 80% of analysts recommend a 'HOLD' rating for Apogee Therapeutics. Average target price of $134.85

Apogee Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Apogee Therapeutics.

What analysts predicted

-0.16%DOWNSIDE

Target Price

$134.85

Current Price

$135.07

Analyzed by

15 Analysts

High

$137

Target

$134.85

Low

$89

Apogee Therapeutics target price $134.85, a slight downside of -0.16% compared to current price of $135.07. According to 15 analysts rating.

Indian Investors' Interest in Apogee Therapeutics Stock

Search interest for Apogee Therapeutics Stock has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-31% versus previous 30 day period

Apogee Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
0
0
0
-
Operating Income
-38
-44
-58
-75
-63
-73
-71
-78
-82
-96
EBITDA
-32
-33
-48
-67
-55
-65
-64
-68
-73
-84
Interest Expense
-
-
-
-
-
-
-
-
-
1
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-32
-33
-49
-67
-55
-66
-64
-69
-74
-85
Income Tax Expense
-
-
-
0
0
0
0
0
0
0
Net Income
-32
-33
-49
-67
-55
-66
-65
-69
-74
-85
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Apogee Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
Gross Profit
-
-
-
-1
Operating Income
-30
-93
-216
-285
EBITDA
-39
-74
-181
-254
Interest Expense
9
-
-
-
Depreciation
-
9
0
1
Income Before Tax
-39
-83
-182
-255
Income Tax Expense
-
-
0
0
Net Income
-39
-83
-182
-255
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Apogee Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-32
-33
-49
-67
-55
-66
-65
-69
-74
-85
Operating Cash Flow
-31
-29
-42
-67
-48
-62
-54
-62
-55
-71
Investing Cash Flow
-51
-148
-146
46
12
78
17
-288
-35
-381
Financing Cash Flow
450
0
0
44
0
1
19
374
411
107
Change in Cash
367
-178
-188
23
-34
17
-16
23
320
-346

Apogee Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-39
-83
-182
-255
Operating Cash Flow
-16
-74
-171
-227
Investing Cash Flow
-
-273
-300
-179
Financing Cash Flow
168
315
495
396
Change in Cash
151
-33
23
-10

Mutual Funds that own Apogee Therapeutics Stock

Check out the Mutual Funds with significant holdings in Apogee Therapeutics.

Funds
Holdings
Shares Held
T. ROWE PRICE CAPITAL APPRECIATION FUND, INC.
8.51421%
5295932
Fidelity Mt. Vernon Street Trust
4.347269%
2704049
VANGUARD INDEX FUNDS
3.9211%
2438967
VANGUARD SPECIALIZED FUNDS
2.396641%
1490737
Fidelity Securities Fund
2.067438%
1285969

Global Institutional Holdings in Apogee Therapeutics

Funds
Holdings
Vanguard
6.51%
David Costen Haley
4.58%
iShares
3.67%
Richard Driehaus
2.8%
SPDR
2.34%

Apogee Therapeutics News & Key Events

  • img

    Today's Timeline - 03 September

    Thu, 06:04 PM

    -

    AbbVie completes acquisition of Apogee Therapeutics for $135.11 per share, totaling approximately $10.9 billion.

    Thu, 06:46 PM

    -

    Apogee Therapeutics announces merger completion and plans to delist from Nasdaq, ceasing trading on September 3, 2026.

Insights on Apogee Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, APGE stock has moved up by 48.6%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, APGE has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 513.1% return, outperforming this stock by 249.3%

About Apogee Therapeutics

Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis, asthma, eosinophilic esophagitis, chronic obstructive pulmonary disease, and other inflammatory and immunology indications in the United States. The company develops Zumilokibart (APG777), a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for the treatment of atopic dermatitis, which is in phase 2 clinical trials; and for the treatment of asthma and eosinophilic esophagitis which is in phase 1 clinical trial. It also develops APG279 which is in phase 1 clinical trial for the treatment of atopic dermatitis; APG273 which is in phase 1 clinical trial for the treatment of asthma and chronic obstructive pulmonary disease; and APG808, an SQ extended half-life mAb targeting IL-4Ra for the treatment of Type 2 allergic diseases. Apogee Therapeutics, Inc. was incorporated in 2022 and is headquartered in Waltham, Massachusetts.
OrganisationApogee Therapeutics
HeadquartersBuilding 17, Waltham, MA, United States, 02453
IndustryBiotechnology
CEODr. Michael Thomas Henderson M.D.
E-voting on sharesClick here to vote

Key Management of Apogee Therapeutics

Name

Title

Dr. Michael Thomas Henderson M.D.

CEO & Director

Ms. Emily Cox

Senior VP & Head of People

Dr. Rebecca Dabora Ph.D.

Chief Development Officer

Ms. Wendy Aspden-Curran

Senior Vice President of Clinical Operations

Dr. Drew Badger Ph.D.

Senior VP and Head of Regulatory Affairs & Toxicology

Ms. Jane Pritchett V. Henderson

Chief Financial Officer

Dr. Carl Linden Dambkowski M.D.

Chief Medical Officer

Ms. Noel Kurdi

Vice President of Investor Relations

Mr. Matthew Batters J.D.

Chief Legal Officer & Corporate Secretary

Ms. Monica Forbes

Senior Vice President of Finance

FAQs

What is Apogee Therapeutics share price today?

Apogee Therapeutics share price today is $135.07 as on . Apogee Therapeutics share today touched a day high of $135.09 and a low of $135.06.

What is the 52 week high and 52 week low for Apogee Therapeutics share?

Apogee Therapeutics share touched a 52 week high of $135.09 on and a 52 week low of $35.39 on . Apogee Therapeutics stock price today i.e. is trending at $135.07,which is 0.01% down from its 52 week high and 281.66% up from its 52 week low.

What is Apogee Therapeutics's market capitalisation today?

Apogee Therapeutics market capitalisation is $0.01T as on .

How to invest in Apogee Therapeutics Stock (APGE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Apogee Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Apogee Therapeutics Shares that will get you 0.0111 shares as per Apogee Therapeutics share price of $135.07 per share as on September 3, 2026 at 8:45 am IST.

What is the minimum amount required to buy Apogee Therapeutics Stock (APGE) from India?

Indian investors can start investing in Apogee Therapeutics (APGE) shares with as little as ₹95.980003356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.80 in Apogee Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Apogee Therapeutics share’s latest price of $135.07 as on September 3, 2026 at 8:45 am IST, you will get 0.0740 shares of Apogee Therapeutics. Learn more about fractional shares .